total cost-of-illness study

MDA has supported a total cost-of-illness study for three common neuromuscular disorders that may affect drug development and social and economic policies

posted on August 14, 2013 - 4:00am
"We now have numbers to point to," said Annie Kennedy, MDA's senior vice president of advocacy. "It's not just a back-of-the-envelope calculation anymore.

New content is being added every day. Please check back again.